- Advertise
- About OncLive
- Editorial Board
- CancerNetwork.com
- CGTlive.com
- CureToday.com
- OncNursingNews.com
- TargetedOnc.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Current and Emerging Trends in Chronic Myeloid Leukemia | Supplements and Featured Publications
Dr. Hobbs on the Role of Molecular Testing to Determine Resistance in CML
January 19, 2021
Video
Gabriela Hobbs, MD, discusses the role of molecular testing to determine resistance in chronic myeloid leukemia.
Dr. Jabbour on Selecting Ponatinib After Second-Generation TKI Failure in CML
January 19, 2021
Video
Elias Jabbour, MD, discusses selecting ponatinib after failure of a second-generation TKI therapy in chronic myeloid leukemia.
Dr. Cortes on the Future of Ponatinib in CML Treatment
January 18, 2021
Video
Jorge E. Cortes, MD, discusses the future of ponatinib in the treatment of patients with chronic myeloid leukemia.
Dr. Hobbs on Choosing Optimal Second-Line Treatment Option for TKI-Resistant CLL
January 07, 2021
Video
Gabriela Hobbs, MD, shares advice on how to choose the appropriate second-line treatment option for patients with chronic lymphocytic leukemia who are resistant to TKIs.
Dr. Sweet on Key Findings From the OPTIC Trial With Ponatinib in CML
January 07, 2021
Video
Kendra Sweet, MD, discusses key findings from the OPTIC trial with ponatinib in chronic myeloid leukemia.
Dr. Sweet on the Awareness and Mitigation of AEs Associated With Ponatinib in CML
January 07, 2021
Video
Kendra Sweet, MD, discusses efforts made to mitigate toxicities associated with ponatinib in patients with chronic myeloid leukemia.
Dr. Cortes on Navigating Among Frontline TKIs in the CML Paradigm
December 17, 2020
Video
Jorge E. Cortes, MD, shares advice for navigating among first- and second-generation TKIs in the frontline treatment of patients with chronic myeloid leukemia.
Dr. Jabbour on the ASCEMBL Data With Asciminib in Chronic-Phase CML
December 17, 2020
Video
Elias Jabbour, MD, discusses data with asciminib in patients with chronic-phase chronic myeloid leukemia.
Dr. Hobbs on Managing Ponatinib-Associated Toxicities in CML
December 15, 2020
Video
Gaby Hobbs, MD, discusses managing ponatinib-associated toxicities in chronic myeloid leukemia.
Dr. Sweet on Treatment Selection With TKIs in CML
December 15, 2020
Video
Kendra Sweet, MD, discusses treatment selection with TKIs in chronic myeloid leukemia.